Summary:
Spectroscopy has shown to be of value in determining benign from malignant tissue.
Incorporation of spectroscopic measurements may increase the diagnostic yield of transthoracic needle biopsies. Given the increasing amount of incidentally found lung lesions, such a technique may prevent unnecessary invasive procedures and uncertainty for the patient.
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Author Manuscript Published OnlineFirst on October 19, 2015; DOI: 10.1158/1078-0432. CCR-15-1999 In this issue of Clinical Cancer Research, Spliethoff et al. describe the feasibility of an innovative technique with a spectral tissue sensing probe at the tip of a biopsy needle during transthoracic needle biopsies of lung lesions (1) . They show that the biopsy needle could guide the interventional physician to the region of interest to increase the diagnostic yield of the procedure. The scientific background of diffuse reflectance spectroscopy in discriminating benign form malignant disease has been described before and is and supported by clinical data (1, 2) . In the present paper Spliethoff et al. translate this knowledge into a clinical applicable technique, which has potentially major clinical impact.
Although the number of patients investigated at present is small with only 11 cases during transthoracic needle biopsies, the technical aspects of the needle together with the limited duration of the procedure do support broader applicability. To decrease the number of false positive findings a number of algorithms have been developed and are used in screening programs (4, 5) . In the Dutch-Belgium NELSON trial volumetric assessments are used in repetitive scans, to determine growth of a lesion (4). This volume doubling time calculation is then used to estimate the change of a SPN being malignant. Another frequently used algorithm is the solitary nodule risk calculators (SPN calculators). Based on the patient characteristics, the aspects of the lesion, etc, the computer calculates the risk of the SPN to be lung cancer (6) .
The key issue remains whether an individual patient will accept that his or her diagnostic workup is based on risk calculation and what is the psychological impact on a patient of the knowledge of having a SPN without a clear diagnosis. Certainly this is the case in these patients who a priori have a higher change of malignancy such as current or former smoker, which are the current inclusion criteria for lungcancer screening. In these individuals, fit enough to undergo treatment, it is questionable whether patients are willing to accept to postpone further workup and diagnostics based on these algorithms. Whether the delay in diagnostics really has an impact on the prognosis of the patient is a matter of debate and further investigation (7).
Apart from this, based on risk calculation without pretreatment pathological sampling, there is an increasing usage of stereotactic irradiation for SPN in non-surgical patients or because of patient preference. This will increase the population of patients treated without a histological diagnosis, as no resection will take place. This ultimately causes an increase of the population who have the stigma of being lung cancer patient with the accompanying follow up, but for a benign disease.
The introduction of advanced imaging techniques like PET-scanning will certainly be off additive value but sensitivity and specificity issues remain.
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All the above mentioned arguments underline the need for proper histopathological diagnosis of lung lesions in a minimal invasive way. To obtain pathological specimens in general a bronchoscopy or a CT-guided biopsy are performed. The diagnostic yield of bronchoscopy for small peripheral lesions is low (8) and in these patients in general a CTguided transthoracic needle biopsy is performed. Although relatively safe with pneumothorax and pulmonary bleeding as major concerns a diagnostic yield of the biopsy is in need for improvement.
It should be clear for interventional pulmonologists and radiologists that it is not only about reaching the lung lesion but also reaching a part of the lesion which yields a diagnosis.
It is not only about reaching the bull's-eye but also making the leg. One of the main reasons for a non diagnostic needle biopsy apart from not reaching the lesion is the fact that the 
information beyond pathology can be obtained. Whether light is scattered or absorbed by the tissue, depends on tissue composition (1, 9) . Analysis of the tissue's spectral response to illumination will provide specific quantitative morphologic, biochemical, and functional information (1, 9) . In the present analysis Spiethoff et al. limit the analysis of the spectrum to an index defined as the relative difference in the water-to-scattering ratio between tumor and lung tissue within the same individual. (1) . From the spectra additional information may be obtained which will open the field investigating physiological data of the tumor and its tumor milieu. In an earlier study we found with optical spectroscopy differences in tumor hypoxia in lungcancer, which was suggested to be prognostic (9).
Although we only at the beginning of analyzing the impact of these factors and therefore can only speculate, knowing the physiological state of the tumor and it milieu may have influence forthcoming treatment decisions. 
